Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Branislav Kucinsky"'
Autor:
Jakub Gazda, Martin Janicko, Sylvia Drazilova, Ivica Grgurevic, Tajana Filipec Kanizaj, Tomas Koller, Beatrica Bodorovska, Maja Mijic, Ivana Mikolasevic, Ivana Knezevic Stromar, Branislav Kucinsky, Matej Gazda, Peter Jarcuska
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2021 (2021)
Background. Ursodeoxycholic acid response score (URS) is a prognostic model that estimates the baseline probability of treatment response after 12 months of ursodeoxycholic acid (UDCA) therapy in patients with primary biliary cholangitis (PBC). Aim.
Externí odkaz:
https://doaj.org/article/069badd8a34845328fd1dec40843f2b8
Autor:
Sylvia Drazilova, Martin Janicko, Pavol Kristian, Ivan Schreter, Branislav Kucinsky, Marek Kozlej, Ivana Hockickova, Peter Jarcuska
Publikováno v:
Gastroenterology Research and Practice, Vol 2016 (2016)
Aim. To evaluate the compliance and virological response to pegylated interferon alpha 2a treatment of chronic hepatitis B in Roma population compared to majority Caucasian population in Slovakia. Methods. Retrospective evaluation of a cohort of all
Externí odkaz:
https://doaj.org/article/c6e963ccf72d49a09a8774fe75ff4e52
Autor:
Ivana Mikolašević, Beatrica Bodorovska, Tajana Filipec Kanizaj, Maja Mijić, Tomas Koller, Martin Janicko, Sylvia Drazilova, Zrinka Rob, Peter Jarcuska, Tonci Bozin, Anita Madir, Branislav Kucinsky, Jakub Gazda, Ivica Grgurević
Publikováno v:
Journal of Personalized Medicine, Vol 11, Iss 495, p 495 (2021)
Journal of Personalized Medicine
Volume 11
Issue 6
Journal of Personalized Medicine
Volume 11
Issue 6
Objective: To identify pretreatment laboratory parameters associated with treatment response and to describe the relationship between treatment response and liver decompensation in patients with primary biliary cholangitis treated with ursodeoxycholi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9fd372e170a0e99b176326edc86fe03
https://www.mdpi.com/2075-4426/11/6/495
https://www.mdpi.com/2075-4426/11/6/495
Autor:
Ivica Grgurević, Beatrica Bodorovska, Tajana Filipec Kanizaj, Ivana Knezevic Stromar, Peter Jarcuska, Sylvia Drazilova, Maja Mijić, Tomas Koller, Ivana Mikolašević, Matej Gazda, Martin Janicko, Jakub Gazda, Branislav Kucinsky
Publikováno v:
Canadian Journal of Gastroenterology & Hepatology
Canadian Journal of Gastroenterology and Hepatology, Vol 2021 (2021)
Canadian Journal of Gastroenterology and Hepatology
Volume 2021
Canadian Journal of Gastroenterology and Hepatology, Vol 2021 (2021)
Canadian Journal of Gastroenterology and Hepatology
Volume 2021
Background: Ursodeoxycholic acid response score (URS) is a prognostic model that estimates the baseline probability of treatment response after 12 months of ursodeoxycholic acid (UDCA) therapy in patients with primary biliary cholangitis (PBC). -----
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d656413b94709795496ac2478f5d5b2
https://pubmed.ncbi.nlm.nih.gov/34258254
https://pubmed.ncbi.nlm.nih.gov/34258254
Autor:
Sylvia, Drazilova, Ingrid, Babinska, Jakub, Gazda, Monika, Halanova, Martin, Janicko, Branislav, Kucinsky, Dominik, Safcak, Dominika, Martinkova, Lucia, Tarbajova, Anna, Cekanova, Peter, Jarcuska
Publikováno v:
International journal of public health. 65(5)
To determine both the incidence and the prevalence of primary biliary cholangitis (PBC) in Eastern Slovakia and to describe its clinical course and the response to ursodeoxycholic acid (UDCA). We recorded data of patients with PBC, who were followed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6065f44aeade52a5656c372312953c06
https://pubmed.ncbi.nlm.nih.gov/32500239
https://pubmed.ncbi.nlm.nih.gov/32500239
Autor:
Martin Janicko, Pavol Kristian, Sylvia Drazilova, Marek Kozlej, Peter Jarcuska, Ivana Hockicková, Branislav Kucinsky, Ivan Schréter
Publikováno v:
Gastroenterology Research and Practice, Vol 2016 (2016)
Gastroenterology Research and Practice
Gastroenterology Research and Practice
Aim. To evaluate the compliance and virological response to pegylated interferon alpha 2a treatment of chronic hepatitis B in Roma population compared to majority Caucasian population in Slovakia.Methods. Retrospective evaluation of a cohort of all R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6349470d68dc9378313ddbc2cb343a0a